Results 11 to 20 of about 1,300,723 (292)

Type 2 diabetes clusters in the Novosibirsk region

open access: yesСахарный диабет, 2023
BACKGROUND: Type 2 diabetes mellitus (T2DM) is a heterogeneous disease. Determination of different T2DM phenotypes will improve the prediction of metabolic disorders, the risk of complications and individual diabetes therapy.AIM: To identify clusters of ...
I. A. Bondar, O. Y. Shabelnikova
doaj   +1 more source

May C-peptide index be a new marker to predict proteinuria in anemic patients with type 2 diabetes mellitus?

open access: yesEndocrine Regulations, 2020
Objective. C-peptide is a reliable marker of beta cell reserve and is associated with diabetic complications. Furthermore, HbA1c level is associated with micro- and macro-vascular complications in diabetic patients. HbA1c measurement of diabetic patients
Katipoglu Bilal   +4 more
doaj   +1 more source

Comparison of Insulin Resistance in Lean and Obese Adults with Type 2 Diabetes Mellitus- A Cross-sectional Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2020
Introduction: Insulin Resistance (IR) can develop into type 2 diabetes mellitus and is closely associated with obesity. However, the non-obese population has also shown a predisposition to the risk of IR due to genetics.
Sandinti Deepa   +5 more
doaj   +1 more source

Prenatal Ultrasonographic Markers of Macrossomia and C-Peptide in Gestational Diabetes Mellitus: A Prospective Cohort Study. [PDF]

open access: goldDiagnostics (Basel)
Galluzzo RN   +8 more
europepmc   +3 more sources

A Versatile Model of Microfluidic Perifusion System for the Evaluation of C-Peptide Secretion Profiles: Comparison Between Human Pancreatic Islets and HLSC-Derived Islet-Like Structures

open access: yesBiomedicines, 2020
A robust and easy-to-use tool for the ex vivo dynamic evaluation of pancreatic islet (PI) function is essential for further development of novel cell-based therapeutic approaches to treating diabetes.
Yonathan Gomez   +4 more
doaj   +1 more source

Intracellular Signalling by C‐Peptide [PDF]

open access: yesJournal of Diabetes Research, 2008
C‐peptide, a cleavage product of the proinsulin molecule, has long been regarded as biologically inert, serving merely as a surrogate marker for insulin release. Recent findings demonstrate both a physiological and protective role of C‐peptide when administered to individuals with type I diabetes.
Hills, Claire E., Brunskill, Nigel J.
openaire   +3 more sources

Low rate of latent autoimmune diabetes in adults (LADA) in patients followed for type 2 diabetes: A single center’s experience in Turkey

open access: yesArchives of Endocrinology and Metabolism, 2020
Objective In this study, we aimed to determine the frequency of and the clinical and metabolic features of patients with latent autoimmune diabetes in adults (LADA) at a single center in Turkey.
Abbas Ali Tam   +8 more
doaj   +1 more source

Evaluation of hemolysis interference and possible protective effect of N-phenyl maleimide on the measurement of small peptides

open access: yesTürk Biyokimya Dergisi, 2022
This study aims to demonstrate that proteolytic enzymes released as a result of hemolysis decrease the small peptide hormones, whereas N-phenyl maleimide (NPM) can be used to prevent hemolysis interference.
Durmaz Mustafa, Erguder Imge
doaj   +1 more source

Association between a novel G94A single nucleotide polymorphism in ATP1A1 gene and type 2 diabetes mellitus among Egyptian patients

open access: yesJournal of Research in Medical Sciences, 2019
Background: Na+/K+ ATPase enzyme is essential for nerve cell membrane integrity, and reduction in its activity, probably due to ATP1A1 gene polymorphisms, is related to diabetic neuropathy progression.
Mohammed A Abosheasha   +4 more
doaj   +1 more source

Assessing MicroRNA-375 Levels in Type 2 Diabetes Mellitus (T2DM) Patients and Their First-Degree Relatives with T2DM

open access: yesDiabetes, Metabolic Syndrome and Obesity, 2021
Xu Wu, Yashan Li, Baohua Man, Dexuan Li The Third People’s Hospital of Yunnan Province, Department of Clinical Laboratory, Kunming, 650200, People’s Republic of ChinaCorrespondence: Dexuan LiDepartment of Clinical Laboratory, The Third People&
Wu X, Li Y, Man B, Li D
doaj  

Home - About - Disclaimer - Privacy